Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Sla | Rat | 1,1-dichloroethene | increases expression | ISO | Sla (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of SLA mRNA | CTD | PMID:26682919 | Sla | Rat | 1,2-dichloroethane | decreases expression | ISO | Sla (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SLA mRNA | CTD | PMID:28960355 | Sla | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Sla (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of SLA mRNA | CTD | PMID:22206623 | Sla | Rat | 17beta-estradiol | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of SLA mRNA; [Estradiol co-treated with more ... | CTD | PMID:22217510|PMID:30165855 | Sla | Rat | 17beta-estradiol | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Estradiol results in decreased expression of SLA mRNA | CTD | PMID:39298647 | Sla | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLA mRNA | CTD | PMID:32741896 | Sla | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLA mRNA | CTD | PMID:32741896 | Sla | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression more ... | CTD | PMID:25975270 | Sla | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLA mRNA | CTD | PMID:34747641 | Sla | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sla (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLA mRNA | CTD | PMID:28922406 | Sla | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | SLA (Homo sapiens) | 6480464 | 2,2',4,4',5-brominated diphenyl ether results in decreased expression of SLA mRNA | CTD | PMID:26705709 | Sla | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Sla (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SLA mRNA | CTD | PMID:39298647 | Sla | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SLA mRNA | CTD | PMID:28973697 | Sla | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Decitabine results in increased expression of SLA mRNA | CTD | PMID:19194470 | Sla | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SLA mRNA | CTD | PMID:24780913 | Sla | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SLA mRNA | CTD | PMID:31881176 | Sla | Rat | all-trans-retinoic acid | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of SLA mRNA; Cycloheximide inhibits the more ... | CTD | PMID:15894607|PMID:9020066 | Sla | Rat | all-trans-retinoic acid | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SLA mRNA | CTD | PMID:15498508|PMID:15894607|PMID:17218384|PMID:33167477|PMID:9020066 | Sla | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of SLA mRNA | CTD | PMID:35163327 | Sla | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SLA mRNA | CTD | PMID:16483693 | Sla | Rat | antirheumatic drug | decreases expression | ISO | SLA (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SLA mRNA | CTD | PMID:24449571 | Sla | Rat | arsenous acid | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SLA mRNA | CTD | PMID:15894607 | Sla | Rat | bathocuproine disulfonic acid | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] more ... | CTD | PMID:15477007 | Sla | Rat | benzo[a]pyrene | decreases expression | ISO | SLA (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLA mRNA | CTD | PMID:20064835 | Sla | Rat | benzo[a]pyrene | affects methylation | ISO | SLA (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLA 3' UTR; Benzo(a)pyrene affects the methylation of SLA intron | CTD | PMID:27901495|PMID:30157460 | Sla | Rat | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of SLA mRNA | CTD | PMID:33789034 | Sla | Rat | bisphenol A | increases expression | ISO | SLA (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SLA mRNA | CTD | PMID:33476716 | Sla | Rat | bisphenol A | increases expression | ISO | Sla (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLA mRNA | CTD | PMID:38701888 | Sla | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLA mRNA | CTD | PMID:30816183|PMID:38750585 | Sla | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLA mRNA | CTD | PMID:25181051 | Sla | Rat | bisphenol F | decreases expression | ISO | Sla (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SLA mRNA | CTD | PMID:36706583 | Sla | Rat | butanal | increases expression | ISO | SLA (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of SLA mRNA | CTD | PMID:26079696 | Sla | Rat | Butylbenzyl phthalate | increases methylation | ISO | Sla (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of SLA intron | CTD | PMID:28392331 | Sla | Rat | cadmium atom | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLA more ... | CTD | PMID:37236586 | Sla | Rat | cadmium dichloride | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLA more ... | CTD | PMID:37236586 | Sla | Rat | calcitriol | decreases expression | ISO | SLA (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of SLA mRNA | CTD | PMID:26485663 | Sla | Rat | carbon nanotube | increases expression | ISO | Sla (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of SLA mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681|PMID:25620056 | Sla | Rat | CGP 52608 | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLA gene] | CTD | PMID:28238834 | Sla | Rat | chloroprene | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Chloroprene results in decreased expression of SLA mRNA | CTD | PMID:23125180 | Sla | Rat | chlorpyrifos | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SLA mRNA | CTD | PMID:34289071 | Sla | Rat | choline | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Sla | Rat | chromium(6+) | affects expression | ISO | Sla (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of SLA mRNA | CTD | PMID:28472532 | Sla | Rat | cisplatin | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SLA mRNA | CTD | PMID:27594783 | Sla | Rat | clofibrate | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SLA mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 | Sla | Rat | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SLA mRNA | CTD | PMID:30556269 | Sla | Rat | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SLA mRNA | CTD | PMID:30556269 | Sla | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of SLA mRNA | CTD | PMID:27523638 | Sla | Rat | cycloheximide | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Tretinoin results in increased expression of SLA mRNA] | CTD | PMID:9020066 | Sla | Rat | cylindrospermopsin | increases expression | ISO | SLA (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of SLA mRNA | CTD | PMID:24921660 | Sla | Rat | cytarabine | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Cytarabine results in increased expression of SLA mRNA | CTD | PMID:19194470 | Sla | Rat | dexamethasone | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of SLA mRNA | CTD | PMID:12782123 | Sla | Rat | dexamethasone | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of SLA mRNA | CTD | PMID:21041162 | Sla | Rat | diarsenic trioxide | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SLA mRNA | CTD | PMID:15894607 | Sla | Rat | fluoranthene | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLA mRNA | CTD | PMID:28329830 | Sla | Rat | folic acid | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Sla | Rat | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of SLA mRNA | CTD | PMID:24915197 | Sla | Rat | hypochlorous acid | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of SLA mRNA | CTD | PMID:19376150 | Sla | Rat | ionomycin | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] more ... | CTD | PMID:15477007 | Sla | Rat | isotretinoin | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Isotretinoin results in increased expression of SLA mRNA | CTD | PMID:20436886 | Sla | Rat | L-methionine | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Sla | Rat | lipopolysaccharide | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLA mRNA | CTD | PMID:35811015 | Sla | Rat | N-(6-acetamidohexyl)acetamide | decreases expression | ISO | Sla (Mus musculus) | 6480464 | hexamethylene bisacetamide results in decreased expression of SLA mRNA | CTD | PMID:26941288 | Sla | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of SLA mRNA | CTD | PMID:25380136 | Sla | Rat | nickel atom | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Nickel results in increased expression of SLA mRNA | CTD | PMID:25583101 | Sla | Rat | paracetamol | multiple interactions | ISO | Sla (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SLA mRNA; PPARA affects the reaction [[Clofibrate more ... | CTD | PMID:17585979 | Sla | Rat | paracetamol | decreases expression | ISO | SLA (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SLA mRNA | CTD | PMID:21420995 | Sla | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] more ... | CTD | PMID:15477007 | Sla | Rat | pyrrolidine dithiocarbamate | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] more ... | CTD | PMID:15477007 | Sla | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of SLA mRNA | CTD | PMID:25905778 | Sla | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SLA (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLA mRNA | CTD | PMID:35811015 | Sla | Rat | silicon dioxide | decreases expression | ISO | Sla (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of SLA mRNA | CTD | PMID:19073995 | Sla | Rat | silicon dioxide | increases expression | ISO | Sla (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of SLA mRNA | CTD | PMID:29341224 | Sla | Rat | sodium arsenate | decreases expression | ISO | Sla (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of SLA mRNA | CTD | PMID:39847705 | Sla | Rat | sodium arsenite | decreases expression | ISO | Sla (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SLA mRNA | CTD | PMID:37682722 | Sla | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SLA mRNA | CTD | PMID:19281266 | Sla | Rat | tacrolimus hydrate | increases expression | ISO | Sla (Mus musculus) | 6480464 | Tacrolimus results in increased expression of SLA mRNA | CTD | PMID:29362864 | Sla | Rat | tamibarotene | increases expression | ISO | SLA (Homo sapiens) | 6480464 | tamibarotene results in increased expression of SLA mRNA | CTD | PMID:15498508 | Sla | Rat | tebuconazole | increases expression | ISO | SLA (Homo sapiens) | 6480464 | tebuconazole results in increased expression of SLA mRNA | CTD | PMID:30458266 | Sla | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLA mRNA | CTD | PMID:32741896 | Sla | Rat | testosterone | increases expression | ISO | Sla (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of SLA mRNA | CTD | PMID:33848595 | Sla | Rat | titanium dioxide | increases expression | ISO | Sla (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SLA mRNA | CTD | PMID:23557971 | Sla | Rat | triclosan | increases expression | ISO | SLA (Homo sapiens) | 6480464 | Triclosan results in increased expression of SLA mRNA | CTD | PMID:30510588 | Sla | Rat | trimellitic anhydride | increases expression | ISO | Sla (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SLA mRNA | CTD | PMID:19042947 | Sla | Rat | triphenyl phosphate | affects expression | ISO | SLA (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SLA mRNA | CTD | PMID:37042841 | Sla | Rat | triptonide | increases expression | ISO | Sla (Mus musculus) | 6480464 | triptonide results in increased expression of SLA mRNA | CTD | PMID:33045310 | Sla | Rat | trovafloxacin | decreases expression | ISO | Sla (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of SLA mRNA | CTD | PMID:35537566 | Sla | Rat | valproic acid | increases methylation | ISO | SLA (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SLA gene | CTD | PMID:29154799 | Sla | Rat | valproic acid | affects expression | ISO | SLA (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLA mRNA | CTD | PMID:25979313 | Sla | Rat | vorinostat | increases expression | ISO | Sla (Mus musculus) | 6480464 | vorinostat results in increased expression of SLA mRNA | CTD | PMID:26941288 | Sla | Rat | zebularine | increases expression | ISO | SLA (Homo sapiens) | 6480464 | pyrimidin-2-one beta-ribofuranoside results in increased expression of SLA mRNA | CTD | PMID:19194470 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















